RETRACTION: Mechanism of LncRNA ROR promoting prostate cancer by regulating Akt (Retraction of Vol 23, Pg 1969, 2019)

被引：0
|
作者：
Zhai, X. -Q. [1 ]
Meng, F. -M. [1 ]
Hu, S. -F. [1 ]
Sun, P. [1 ]
Xu, W. [1 ]
机构：
[1] Zoucheng Peoples Hosp, Dept Urol Surg, Zoucheng, Peoples R China
来源：
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES | 2021年 / 25卷 / 05期
关键词：
D O I：
10.26355/eurrev_202103_25195
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：2155 / 2155
页数：1
相关论文
共 50 条
  • [1] RETRACTION: LncRNA TUG1 aggravates the progression of prostate cancer and predicts the poor prognosis (Retraction of Vol 23, Pg 4698, 2019)
    Xu, T.
    Liu, C. -L.
    Li, T.
    Zhang, Y. -H.
    Zhao, Y. -H.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (09) : 3057 - 3057
  • [2] RETRACTION: A Glycolytic Mechanism Regulating an Angiogenic Switch in Prostate Cancer (Retraction of Vol 67, Pg 149, 2007)
    Wang, Jianhua
    Wang, Jincheng
    Dai, Jinlu
    Jung, Younghun
    Wei, Chuen-Long
    Wang, Yu
    Havens, Aaron M.
    Hogg, Phillip J.
    Keller, Evan T.
    Pienta, Kenneth J.
    Nor, Jacques E.
    Wang, Cun-Yu
    Taichman, Russell S.
    [J]. CANCER RESEARCH, 2021, 81 (06) : 1623 - 1623
  • [3] RETRACTED: Mechanism of LncRNA ROR promoting prostate cancer by regulating Akt (Retracted article. See vol. 25, pg. 2155, 2021)
    Zhai, X-Q
    Meng, F-M
    Hu, S-F
    Sun, P.
    Xu, W.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (05) : 1969 - 1977
  • [4] RETRACTION: Regulatory effect of lncRNA NKILA on autophagy induced by sepsis kidney injury (Retraction of Vol 23, Pg 8011, 2019)
    Yang, Y. -M.
    Li, Y. -H.
    Ding, L. -L.
    Fu, Y.
    Li, N.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (08) : 4057 - 4057
  • [5] RETRACTION: LncRNA CASC15 promotes migration and invasion in prostate cancer via targeting miR-200a-3p (Retraction of Vol 23, Pg 8303, 2019)
    Zhang, C.
    Wang, G. -X.
    Fu, B.
    Zhou, X. -C.
    Li, Y.
    Li, Y. -Y.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (13) : 7215 - 7215
  • [6] RETRACTION: MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2 (Retraction of Vol 23, Pg 8795, 2019)
    Pan, M. -Z.
    Song, Y. -L.
    Gao, F.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (05) : 2156 - 2156
  • [7] RETRACTION: Correlation of SOX9 and NM23 genes with the incidence and prognosis of prostate cancer (Retraction of Vol 17, Pg 2296, 2019)
    Xi, Ming
    Wan, Song
    Hua, Wei
    Zhou, Yulin
    Jiang, Wencong
    Hu, Jianxin
    [J]. ONCOLOGY LETTERS, 2024, 27 (05)
  • [8] RETRACTION: Knockdown of lncRNA MNX1-AS1 suppresses cell proliferation, migration, and invasion in prostate cancer (Retraction of Vol 9, Pg 851, 2019)
    不详
    [J]. FEBS OPEN BIO, 2022, 12 (12): : 2254 - 2254
  • [9] RETRACTION: lncRNA ROR promotes the progression of renal cell carcinoma through the miR-206/VEGF axis (Retraction of Vol 20, Pg 3782, 2019)
    Shi, Jianguo
    Zhang, Datian
    Zhong, Zhenhai
    Zhang, Wen
    [J]. MOLECULAR MEDICINE REPORTS, 2024, 29 (06)
  • [10] RETRACTION: Retraction to: LINC01638 lncRNA promotes the proliferation, migration and invasion of prostate carcinoma cells by interacting with Notch1 (vol 25, pg 161, 2019) (Retraction of Vol 25, Pg 161, 2019)
    Wu, Zhun
    Huang, Wei
    Chen, Yuedong
    Chen, Bin
    Liu, Rongfu
    Bai, Peide
    Xing, Jinchun
    [J]. CANCER BIOMARKERS, 2023, 37 (03) : 205 - 205
12345